AstraZeneca (AZN) Gains on Novartis (NVS) Chatter

October 17, 2016 11:06 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Upside in AstraZeneca (NYSE: AZN) is being attributed to a vague rumor that Novartis AG (NYSE: NVS) is looking to sell its 33.3% stake in Roche to make a cash bid for AstraZeneca.

AstraZeneca declined to comment on the speculation.

Shares of AZN are up 1.1%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors

Add Your Comment